Do Pharmaceutical Sales Respond to Scientific Evidence?
Author
Abstract
Suggested Citation
DOI: 10.1111/j.1430-9134.2002.00551.x
Download full text from publisher
References listed on IDEAS
- Ernst R. Berndt & Robert S. Pindyck & Pierre Azoulay, 2003.
"Consumption Externalities and Diffusion in Pharmaceutical Markets: Antiulcer Drugs,"
Journal of Industrial Economics, Wiley Blackwell, vol. 51(2), pages 243-270, June.
- Ernst R. Berndt & Robert S. Pindyck & Pierre Azoulay, 2000. "Consumption Externalities and Diffusion in Pharmaceutical Markets: Antiulcer Drugs," NBER Working Papers 7772, National Bureau of Economic Research, Inc.
- Andrea Coscelli, 2000. "The Importance of Doctors’ and Patients’ Preferences in the Prescription Decision," Journal of Industrial Economics, Wiley Blackwell, vol. 48(3), pages 349-369, September.
- Scott Stern & Manuel Trajtenberg, 1998.
"Empirical Implications of Physician Authority in Pharmaceutical Decisionmaking,"
NBER Working Papers
6851, National Bureau of Economic Research, Inc.
- Stern, S. & Trajtenberg, M., 1998. "Empirical Implications of Physician Authority in Pharmaceutical Decisionmaking," Papers 24-98, Tel Aviv.
- Sara Ellison Fisher & Iain Cockburn & Zvi Griliches & Jerry Hausman, 1997.
"Characteristics of Demand for Pharmaceutical Products: An Examination of Four Cephalosporins,"
RAND Journal of Economics, The RAND Corporation, vol. 28(3), pages 426-446, Autumn.
- Ellison, S & Cockburn, I & Griliches, A & Hausman, J, 1996. "Characteristics of Demand for Pharmaceutical Products : an Examination of four Cephalosporins," Working papers 96-24, Massachusetts Institute of Technology (MIT), Department of Economics.
- James Adams & Zvi Griliches, 1996.
"Measuring Science: An Exploration,"
Harvard Institute of Economic Research Working Papers
1749, Harvard - Institute of Economic Research.
- James Adams & Zvi Griliches, 1996. "Measuring Science: An Exploration," NBER Working Papers 5478, National Bureau of Economic Research, Inc.
- Avner Shaked & John Sutton, 1982. "Relaxing Price Competition Through Product Differentiation," The Review of Economic Studies, Review of Economic Studies Ltd, vol. 49(1), pages 3-13.
- Coscelli, Andrea, 2000. "The Importance of Doctors' and Patients' Preferences in the Prescription Decision," Journal of Industrial Economics, Wiley Blackwell, vol. 48(3), pages 349-369, September.
- Manuel Trajtenberg, 1990. "A Penny for Your Quotes: Patent Citations and the Value of Innovations," RAND Journal of Economics, The RAND Corporation, vol. 21(1), pages 172-187, Spring.
- Zvi Griliches, 1984. "R&D, Patents, and Productivity," NBER Books, National Bureau of Economic Research, Inc, number gril84-1, July.
- Iain M. Cockburn & Aslam H. Anis, 2001.
"Hedonic Analysis of Arthritis Drugs,"
NBER Chapters, in: Medical Care Output and Productivity, pages 439-462,
National Bureau of Economic Research, Inc.
- Iain M. Cockburn & Aslam H. Anis, 1998. "Hedonic Analysis of Arthritis Drugs," NBER Working Papers 6574, National Bureau of Economic Research, Inc.
- Milgrom, Paul & Roberts, John, 1986.
"Price and Advertising Signals of Product Quality,"
Journal of Political Economy, University of Chicago Press, vol. 94(4), pages 796-821, August.
- Paul R. Milgrom & John Roberts, 1984. "Price and Advertising Signals of Product Quality," Cowles Foundation Discussion Papers 709, Cowles Foundation for Research in Economics, Yale University.
- Pauline M. Ippolito & Alan D. Mathios, 1990. "Information, Advertising and Health Choices: A Study of the Cereal Market," RAND Journal of Economics, The RAND Corporation, vol. 21(3), pages 459-480, Autumn.
- Hurwitz, Mark A & Caves, Richard E, 1988. "Persuasion or Information? Promotion and the Shares of Brand Name and Generic Pharmaceuticals," Journal of Law and Economics, University of Chicago Press, vol. 31(2), pages 299-320, October.
- Zvi Griliches, 1998.
"R&D and Productivity Growth at the Industry Level: Is There Still a Relationship?,"
NBER Chapters, in: R&D and Productivity: The Econometric Evidence, pages 213-240,
National Bureau of Economic Research, Inc.
- Zvi Griliches & Frank R. Lichtenberg, 1984. "R&D and Productivity Growth at the Industry Level: Is There Still a Relationship?," NBER Chapters, in: R&D, Patents, and Productivity, pages 465-502, National Bureau of Economic Research, Inc.
- Steven T. Berry, 1994. "Estimating Discrete-Choice Models of Product Differentiation," RAND Journal of Economics, The RAND Corporation, vol. 25(2), pages 242-262, Summer.
- Kenneth Arrow, 1962. "Economic Welfare and the Allocation of Resources for Invention," NBER Chapters, in: The Rate and Direction of Inventive Activity: Economic and Social Factors, pages 609-626, National Bureau of Economic Research, Inc.
- Leffler, Keith B, 1981. "Persuasion or Information? The Economics of Prescription Drug Advertising," Journal of Law and Economics, University of Chicago Press, vol. 24(1), pages 45-74, April.
- Uri Ronnen, 1991. "Minimum Quality Standards, Fixed Costs, and Competition," RAND Journal of Economics, The RAND Corporation, vol. 22(4), pages 490-504, Winter.
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.- Toshiaki Iizuka, 2004. "What Explains the Use of Direct‐to‐Consumer Advertising of Prescription Drugs?," Journal of Industrial Economics, Wiley Blackwell, vol. 52(3), pages 349-379, September.
- Lee Branstetter & Chirantan Chatterjee & Matthew J. Higgins, 2016.
"Regulation and welfare: evidence from paragraph IV generic entry in the pharmaceutical industry,"
RAND Journal of Economics, RAND Corporation, vol. 47(4), pages 857-890, November.
- Lee G. Branstetter & Chirantan Chatterjee & Matthew Higgins, 2011. "Regulation and Welfare: Evidence from Paragraph IV Generic Entry in the Pharmaceutical Industry," NBER Working Papers 17188, National Bureau of Economic Research, Inc.
- Lim, Kwanghui, 2004. "The relationship between research and innovation in the semiconductor and pharmaceutical industries (1981-1997)," Research Policy, Elsevier, vol. 33(2), pages 287-321, March.
- Dag Dalen & Steinar Strøm & Tonje Haabeth, 2006.
"Price regulation and generic competition in the pharmaceutical market,"
The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 7(3), pages 204-211, September.
- Dalen, Dag Morten & Strøm, Steinar & Haabeth, Tonje, 2005. "Price regulation and generic competition in the pharmaceutical market," Memorandum 33/2005, Oslo University, Department of Economics.
- Dalen, Dag Morten & Habeth, Tonje & Strøm, Steinar, 2009. "Price regulation and generic competition in the pharmaceutical market," HERO Online Working Paper Series 2006:1, University of Oslo, Health Economics Research Programme.
- Andrew J. Epstein & Jonathan D. Ketcham, 2014. "Information technology and agency in physicians' prescribing decisions," RAND Journal of Economics, RAND Corporation, vol. 45(2), pages 422-448, June.
- Daniel J. Wilson, 2002.
"Is Embodied Technology the Result of Upstream R&D? Industry-Level Evidence,"
Review of Economic Dynamics, Elsevier for the Society for Economic Dynamics, vol. 5(2), pages 285-317, April.
- Daniel J. Wilson, 2001. "Is embodied technology the result of upstream R&D? industry-level evidence," Working Paper Series 2001-17, Federal Reserve Bank of San Francisco.
- Dirk Czarnitzki & Cindy Lopes-Bento, 2014.
"Innovation Subsidies: Does the Funding Source Matter for Innovation Intensity and Performance? Empirical Evidence from Germany,"
Industry and Innovation, Taylor & Francis Journals, vol. 21(5), pages 380-409, July.
- Czarnitzki, Dirk & Lopes Bento, Cindy, 2011. "Innovation subsidies: Does the funding source matter for innovation intensity and performance? Empirical evidence from Germany," ZEW Discussion Papers 11-053, ZEW - Leibniz Centre for European Economic Research.
- CZARNITZKI Dirk & LOPES BENTO Cindy, 2011. "Innovation subsidies: Does the funding source matter for innovation intensity and performance? Empirical evidence from Germany," LISER Working Paper Series 2011-42, Luxembourg Institute of Socio-Economic Research (LISER).
- Castanheira, Micael & Ornaghi, Carmine & Siotis, Georges, 2019.
"The unexpected consequences of generic entry,"
Journal of Health Economics, Elsevier, vol. 68(C).
- Micael Castanheira De Moura & Carmine Ornaghi & Georges Siotis, 2019. "The Unexpected Consequences of Generic Entry," Working Papers ECARES 2019-21, ULB -- Universite Libre de Bruxelles.
- Micael Castanheira De Moura & Georges Siotis & Carmine Ornaghi, 2019. "The Unexpected Consequences of Generic Entry," ULB Institutional Repository 2013/298643, ULB -- Universite Libre de Bruxelles.
- Ugur, Mehmet & Trushin, Eshref & Solomon, Edna & Guidi, Francesco, 2016.
"R&D and productivity in OECD firms and industries: A hierarchical meta-regression analysis,"
Research Policy, Elsevier, vol. 45(10), pages 2069-2086.
- Ugur, Mehmet & Trushin, Eshref & Solomon, Edna & Guidi, Francesco, 2015. "R&D and productivity in OECD firms and industries: A hierarchical meta-regression analysis," MPRA Paper 68008, University Library of Munich, Germany, revised 16 Sep 2015.
- Ugur, Mehmet & Trushin, Eshref & Solomon, Edna & Guidi, Francesco, 2016. "R&D and productivity in OECD firms and industries: a hierarchical meta-regression analysis," Greenwich Papers in Political Economy 15854, University of Greenwich, Greenwich Political Economy Research Centre.
- Ugur, Mehmet & Trushin, Esref & Solomon, Edna M. & Guidi, Francesco, 2015. "R&D and productivity in OECD firms and industries: a hierarchical meta-regression analysis," Greenwich Papers in Political Economy 14080, University of Greenwich, Greenwich Political Economy Research Centre.
- Ugur, Mehmet & Solomon, Edna & Guidi, Francesco & Trushin, Eshref, 2015. "R&D and productivity in OECD firms and industries: A hierarchical meta-regression analysis," EconStor Preprints 109962, ZBW - Leibniz Information Centre for Economics.
- David, Paul A. & Hall, Bronwyn H. & Toole, Andrew A., 2000.
"Is public R&D a complement or substitute for private R&D? A review of the econometric evidence,"
Research Policy, Elsevier, vol. 29(4-5), pages 497-529, April.
- Paul A. David & Bronwyn H. Hall & Andrew A. Toole, 1999. "Is Public R&D a Complement or Substitute for Private R&D? A Review of the Econometric Evidence," NBER Working Papers 7373, National Bureau of Economic Research, Inc.
- Paul A. David & Bronwyn H. Hall & Andrew A. Toole, 2000. "Is Public R&D a Complement or Substitute for Private R&D? A Review of the Econometric Evidence," Development and Comp Systems 9912002, University Library of Munich, Germany.
- Paul A. David & Bronwyn H. Hall & Andrew A. Toole, 2005. "Is Public R&D a Complement or Substitute for Private R&D? A Review of the Econometric Evidence," Development and Comp Systems 0502011, University Library of Munich, Germany.
- David, Paul A. & Hall, Bronwyn H. & Toole, Andrew A., 1999. "Is Public R&D a Complement or Substitute for Private R&D? A Review of the Econometric Evidence," Department of Economics, Working Paper Series qt1sz6g8bv, Department of Economics, Institute for Business and Economic Research, UC Berkeley.
- Paul A. David, Bronwyn H. Hall and Andrew A. Toole., 1999. "Is Public R&D a Complement or Substitute for Private R&D? A Review of the Econometric Evidence," Economics Working Papers E99-269, University of California at Berkeley.
- Paul A. David & Bronwyn H. Hall & Andrew A. Toole, 1999. "Is Public R&D a Complement or Substitute for Private R&D? A Review of the Econometric Evidence," Working Papers 99023, Stanford University, Department of Economics.
- Ruiz-Conde, Enar & Wieringa, Jaap E. & Leeflang, Peter S.H., 2014. "Competitive diffusion of new prescription drugs: The role of pharmaceutical marketing investment," Technological Forecasting and Social Change, Elsevier, vol. 88(C), pages 49-63.
- Ivan Moreno-Torres, 2011. "Generic drugs in Spain: price competition vs. moral hazard," Working Papers XREAP2011-04, Xarxa de Referència en Economia Aplicada (XREAP), revised May 2011.
- Choi, Mincheol & Lee, Chang-Yang, 2021. "Technological diversification and R&D productivity: The moderating effects of knowledge spillovers and core-technology competence," Technovation, Elsevier, vol. 104(C).
- Mark Zachary Taylor, 2007.
"Political Decentralization and Technological Innovation: Testing the Innovative Advantages of Decentralized States,"
Review of Policy Research, Policy Studies Organization, vol. 24(3), pages 231-257, May.
- Taylor, Mark Zachary, 2007. "Political decentralization and technological innovation: testing the innovative advantages of decentralized states," MPRA Paper 10996, University Library of Munich, Germany.
- Damijan, Jože P. & Kostevc, Crt, 2007. "Knowledge Transfer, Innovation and Growth," Papers DYNREG06, Economic and Social Research Institute (ESRI).
- Bergman, Karin, 2011. "Productivity Effects of Privately and Publicly Funded R&D," Working Papers 2011:28, Lund University, Department of Economics.
- Glenn Ellison & Sara Fisher Ellison, 2011.
"Strategic Entry Deterrence and the Behavior of Pharmaceutical Incumbents Prior to Patent Expiration,"
American Economic Journal: Microeconomics, American Economic Association, vol. 3(1), pages 1-36, February.
- Glenn Ellison & Sara Fisher Ellison, 2007. "Strategic Entry Deterrence and the Behavior of Pharmaceutical Incumbents Prior to Patent Expiration," NBER Working Papers 13069, National Bureau of Economic Research, Inc.
- Jože P. Damijan & Andreja Jaklič & Matija Rojec, 2006.
"Do External Knowledge Spillovers Induce Firms’ Innovations? Evidence from Slovenia,"
Palgrave Macmillan Books, in: Ana Teresa Tavares & Aurora Teixeira (ed.), Multinationals, Clusters and Innovation, chapter 3, pages 27-47,
Palgrave Macmillan.
- Joze P. Damijan & Andreja Jaklic & Matija Rojec, 2005. "Do External Knowledge Spillovers Induce Firms'Innovations? Evidence from Slovenia," LICOS Discussion Papers 15605, LICOS - Centre for Institutions and Economic Performance, KU Leuven.
- Joseph Kuehn, 2020. "Strategic Complementarities in Bank Branching Decisions," Journal of Industrial Economics, Wiley Blackwell, vol. 68(4), pages 640-692, December.
- Zvi Griliches, 1998.
"Patent Statistics as Economic Indicators: A Survey,"
NBER Chapters, in: R&D and Productivity: The Econometric Evidence, pages 287-343,
National Bureau of Economic Research, Inc.
- Griliches, Zvi, 1990. "Patent Statistics as Economic Indicators: A Survey," Journal of Economic Literature, American Economic Association, vol. 28(4), pages 1661-1707, December.
- Zvi Griliches, 1990. "Patent Statistics as Economic Indicators: A Survey," NBER Working Papers 3301, National Bureau of Economic Research, Inc.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:bla:jemstr:v:11:y:2002:i:4:p:551-594. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Wiley Content Delivery (email available below). General contact details of provider: http://www.kellogg.northwestern.edu/research/journals/JEMS/ .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.